COMPOSITION:
Levocetrizine 2.5mg + Montelukast 4mg
For the Treatment of
- Allergic Rhinitis
- Asthmatic Bronchitis
- Urticaria
- Allergic Asthma
- Allergic Rhinitis co morbid with Asthma
Montelukast
- Selective leukotriene antagonist.
- Montelukast is USFDA approved for the treatment of chronic asthma. (3)
- Reduces the risk of excessive airway narrowing in persistent Asthma. (4)
Levocetrizine
- Neutralizing the effect of Histamines and use to treat allergic symptoms.
- “Excellent effect on nasal obstruction as early as over first 2 hours & sustained over 6 weeks” (5)